SinoGreenTech Academic Portal
LW
Verified CAS / Academic Author2 Decoded Studies

Prof. LIU Weimin

University of Chinese Academy of Sciences

Research Publications & English Decoded Briefs

Showing 2 publications
SCIENCE CHINA Materials2026DOI: 10.1007/s40843-025-4018-6

Cryogenic Tribological Breakthroughs in Medium-Entropy Alloy Composites via Regulated Partial Recrystallization

The pursuit of advanced wear-resistant materials for cryogenic applications is often hindered by a fundamental trade-off between enhancing strength and damage tolerance. CoCrNi-based medium-entropy alloys (MEAs), while excellent in cryogenic toughness, suffer from this very limitation. Although second-phase reinforcement boosts strength, the strain incompatibility between phases inevitably triggers cracking, which is severely exacerbated at low temperatures. This work introduces a novel microstructural design strategy based on regulated partial recrystallization to overcome this long-standing challenge. By tailoring the thermomechanical processing of a (CoCrNi)90Mo10 MEA, we engineered a unique architecture where a fully recrystallized FCC phase is homogeneously embedded within a continuous skeleton of a hard, non-recrystallized σ phase. The alloy with this optimized microstructure achieved a remarkably low wear rate at 113 K that is less than half of its as-cast and fully recrystallized counterparts. The experimental and modeling results indicate the underlying synergy: the σ skeleton provides robust structural support and distributes stress deeply, while the recrystallized FCC phase, with its high density of grain boundaries and annealing twins, acts as a compliant strain-accommodating medium, effectively suppressing interfacial cracking. This combined 'skeleton effect' and 'recrystallization effect' not only delivers exceptional cryogenic wear resistance but also offers a practical strategy for designing high-performance, crack-resistant dual-phase composites for extreme environments.

SCIENCE CHINA Materials2025DOI: 10.1007/s40843-025-3548-9

Dual-Responsive Peptide-Photosensitizer Conjugate Based on a Hypocrellin Derivative for Tumor-Targeted Photodynamic Therapy

Photodynamic therapy (PDT) is constrained by the absence of tumor selectivity in conventional photosensitizers (PSs), which produces phototoxicity in normal tissues and risks activation by ambient light. Covalent conjugation of PSs to targeting peptides improves accumulation but does not suppress off-target activation. This work reports B-HCPP-RGD, a single-molecule PS that integrates αVβ3 integrin targeting with dual responsiveness to H2O2 and cathepsin B. The hypocrellin-derived type I PS HCEA is masked by a 4-(bromomethyl)phenylboronic acid pinacol ester H2O2-responsive group and conjugated to cyclic Arg-Gly-Asp (cRGD) through a cathepsin B-cleavable Gln-Val dipeptide linker. ROS generation in solution is effectively suppressed until both H2O2 and cathepsin B are present, at which point HCEA is released. In vitro, B-HCPP-RGD shows negligible phototoxicity toward normal cells and pronounced phototoxicity toward tumor cells, including under hypoxic conditions. In vivo, the conjugate actively targets tumor tissue and achieves a high tumor inhibition rate with favorable biosafety. The results establish a modular design for dual-responsive, tumor-targeted PSs that improves the precision and safety of PDT.